{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:39:09Z","timestamp":1794645549639,"version":"4.9.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007750","name":"National Cheng Kung University, Taiwan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST107-2321-B-007-003"],"award-info":[{"award-number":["MOST107-2321-B-007-003"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST105-2321-B-007-005"],"award-info":[{"award-number":["MOST105-2321-B-007-005"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.antiviral.2019.02.004","type":"journal-article","created":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T21:04:51Z","timestamp":1549746291000},"page":"12-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Highly immunogenic influenza virus-like particles containing B-cell-activating factor (BAFF) for multi-subtype vaccine development"],"prefix":"10.1016","volume":"164","author":[{"given":"Jo-Yu","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Hsuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6257-0389","authenticated-orcid":false,"given":"Chia-Chyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Tsrong","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suh-Chin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.antiviral.2019.02.004_bib1","doi-asserted-by":"crossref","first-page":"10612","DOI":"10.1128\/JVI.01526-15","article-title":"Enhanced influenza virus-like particle vaccination with a structurally optimized RIG-I agonist as adjuvant","volume":"89","author":"Beljanski","year":"2015","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.antiviral.2019.02.004_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.smim.2006.04.006","article-title":"BAFF, APRIL and their receptors: structure, function and signaling","volume":"18","author":"Bossen","year":"2006","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.antiviral.2019.02.004_bib3","doi-asserted-by":"crossref","first-page":"e1501","DOI":"10.1371\/journal.pone.0001501","article-title":"Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle","volume":"3","author":"Bright","year":"2008","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.antiviral.2019.02.004_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1467-7652.2009.00496.x","article-title":"The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza","volume":"8","author":"D'Aoust","year":"2010","journal-title":"Plant Biotechnol. J"},{"key":"10.1016\/j.antiviral.2019.02.004_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: a review on adjuvants in licensed vaccines","volume":"39","author":"Del Giudice","year":"2018","journal-title":"Semin. Immunol."},{"issue":"16","key":"10.1016\/j.antiviral.2019.02.004_bib6","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.vaccine.2011.01.100","article-title":"A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets","volume":"29","author":"Giles","year":"2011","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.antiviral.2019.02.004_bib7","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/infdis\/jis232","article-title":"A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection","volume":"205","author":"Giles","year":"2012","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.antiviral.2019.02.004_bib8","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1128\/JVI.02904-14","article-title":"DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers","volume":"89","author":"Gupta","year":"2015","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.antiviral.2019.02.004_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02435-16","article-title":"Targeting vaccine-induced extrafollicular pathway of B cell differentiation improves rabies postexposure prophylaxis","volume":"91","author":"Haley","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.02.004_bib11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1586\/erv.09.8","article-title":"Influenza virus-like particle vaccines","volume":"8","author":"Haynes","year":"2009","journal-title":"Expert Rev. Vaccines"},{"issue":"12","key":"10.1016\/j.antiviral.2019.02.004_bib12","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1128\/CVI.05206-11","article-title":"Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza","volume":"18","author":"Hossain","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.antiviral.2019.02.004_bib13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1586\/14760584.2013.811204","article-title":"Adjuvants containing natural and synthetic Toll-like receptor 4 ligands","volume":"12","author":"Ireton","year":"2013","journal-title":"Expert Rev. Vaccines"},{"issue":"1","key":"10.1016\/j.antiviral.2019.02.004_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4049\/jimmunol.1600173","article-title":"Roles of aluminum hydroxide and monophosphoryl lipid a adjuvants in overcoming CD4+ T cell deficiency to induce isotype-switched IgG antibody responses and protection by T-dependent influenza vaccine","volume":"198","author":"Ko","year":"2017","journal-title":"J. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.antiviral.2019.02.004_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0022-1759(90)90255-T","article-title":"Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates","volume":"135","author":"Lambre","year":"1990","journal-title":"J. Immunol. Methods"},{"issue":"12","key":"10.1016\/j.antiviral.2019.02.004_bib16","doi-asserted-by":"crossref","first-page":"e15559","DOI":"10.1371\/journal.pone.0015559","article-title":"Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza","volume":"5","author":"Landry","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.antiviral.2019.02.004_bib17","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/biot.201300116","article-title":"Heterologous prime-boost immunization regimens using adenovirus vector and virus-like particles induce broadly neutralizing antibodies against H5N1 avian influenza viruses","volume":"8","author":"Lin","year":"2013","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.antiviral.2019.02.004_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2016.07.021","article-title":"Multi-subtype influenza virus-like particles incorporated with flagellin and granulocyte-macrophage colony-stimulating factor for vaccine design","volume":"133","author":"Liu","year":"2016","journal-title":"Antivir. Res."},{"issue":"3","key":"10.1016\/j.antiviral.2019.02.004_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4161\/hv.18757","article-title":"Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic","volume":"8","author":"Lopez-Macias","year":"2012","journal-title":"Hum. Vaccines Immunother."},{"issue":"8","key":"10.1016\/j.antiviral.2019.02.004_bib20","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nm.2403","article-title":"DNA released from dying host cells mediates aluminum adjuvant activity","volume":"17","author":"Maricha","year":"2011","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.antiviral.2019.02.004_bib21","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1128\/JVI.06259-11","article-title":"Targeting HIV-1 envelope glycoprotein trimers to B cells by using APRIL improves antibody responses","volume":"86","author":"Melchers","year":"2012","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.antiviral.2019.02.004_bib22","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1128\/JVI.00207-09","article-title":"Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge","volume":"83","author":"Perrone","year":"2009","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.antiviral.2019.02.004_bib23","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1128\/JVI.02052-06","article-title":"Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus","volume":"81","author":"Quan","year":"2007","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.antiviral.2019.02.004_bib24","doi-asserted-by":"crossref","first-page":"e6032","DOI":"10.1371\/journal.pone.0006032","article-title":"A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets","volume":"4","author":"Ross","year":"2009","journal-title":"PLoS One"},{"issue":"27","key":"10.1016\/j.antiviral.2019.02.004_bib25","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1016\/j.vaccine.2016.04.081","article-title":"Toward understanding the mechanism underlying the strong adjuvant activity of aluminum salt nanoparticles","volume":"34","author":"Ruwona","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.antiviral.2019.02.004_bib26","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/CMR.00046-17","article-title":"The role of BAFF system molecules in host response to pathogens","volume":"30","author":"Sakai","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"issue":"26","key":"10.1016\/j.antiviral.2019.02.004_bib27","doi-asserted-by":"crossref","first-page":"16330","DOI":"10.1074\/jbc.M115.661405","article-title":"Stoichiometry of heteromeric BAFF and APRIL cytokines dictates their receptor binding and signaling properties","volume":"290","author":"Schuepbach-Mallepell","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"41","key":"10.1016\/j.antiviral.2019.02.004_bib28","doi-asserted-by":"crossref","first-page":"7163","DOI":"10.1016\/j.vaccine.2011.05.077","article-title":"Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines","volume":"29","author":"Wei","year":"2011","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.antiviral.2019.02.004_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042363","article-title":"A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.antiviral.2019.02.004_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013972","article-title":"Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection","volume":"5","author":"Wang","year":"2010","journal-title":"PLoS One"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218306557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218306557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T16:45:05Z","timestamp":1565196305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218306557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":29,"alternative-id":["S0166354218306557"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.02.004","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly immunogenic influenza virus-like particles containing B-cell-activating factor (BAFF) for multi-subtype vaccine development","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}